// App-Quantinova.ai

4695 : Functional group elaboration of a low molecular weight fragment to yield the novel BET family bromodomain inhibitor ABBV-075

Researchers

Presenter

  • Keith McDaniel

Principal Investigators

  • George Sheppard

  • Steve Fidanze

  • John Pratt

  • Dachun Liu

  • Lisa Hasvold

  • Robert Mantei

  • Chang Park

  • Aparna Sarthy

  • Leiming Li

  • Daniel H. Albert

  • Xiaoyu Lin

  • Scott Warder

  • Emily Faivre

  • Mai H. Bui

  • Xiaoli Huang

  • Denise Wilcox

  • Rongqi Wang

  • Terry Magoc

  • Ganesh Rajaraman

  • Andrew Petros

  • Sanjay Panchal

  • Chaohong Sun

  • Guowei Fang

  • Steven W. Elmore

  • Saul Rosenberg

  • Yu Shen

  • Warren Kati

Medical Centers

  • AbbVie, Inc., North Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • abbv-075

Outcome

  • N/A


Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A